(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Departure of Director and Senior Executive
Filed with SSE · Stock code 600223 · · 1 page · Chinese
Summary by 6ix AI
Lushang Freda Pharmaceutical Co., Ltd. has announced the departure of a director and a senior executive due to age reasons.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Lushang Freda Pharmaceutical Co., Ltd. on 6ix
Story so far
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
- Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party Transactions
Earlier from Lushang Freda Pharmaceutical
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party Transactions
- Announcement on Progress in Transfer of Certain Company Shares under Agreement by Controlling Shareholder and Changes in Equity Interests
Later from Lushang Freda Pharmaceutical
All Lushang Freda Pharmaceutical news releasesFollow Lushang Freda Pharmaceutical into a list and get an email when it puts out news.
Follow Lushang Freda Pharmaceutical